the effect of fanetizole mesylate or cp-48,810 , a new immunostimulating drug , on suppressor cell function and ige synthesis in vitro was evaluated in atopic patients with allergic rhinitis and/or asthma and eczema .
C1334103
allergic rhinitis
C0004096
asthma